Instrument Inactif

Communiqués MiMedx Group Inc Nasdaq

Actions

US6024961012

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer	26/06	AQ
4 Stocks to Watch in the Booming Regenerative Medicine Market	20/05	AQ
MIMEDX to Participate in Upcoming Investor Conferences	15/05	AQ
MiMedx: Q1 Earnings Snapshot	30/04	AQ
MIMEDX Announces First Quarter 2024 Operating and Financial Results	30/04	AQ
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30	16/04	AQ
MIMEDX Provides Update on AXIOFILL Request for Designation from FDA	28/03	AQ
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024	27/03	AQ
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA	27/03	AQ
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	20/03	AQ
MIMEDX Introduces E-Commerce and Account Management Platform	13/03	AQ
MIMEDX Announces Appointment of Two New Independent Directors	04/03	AQ
MiMedx: Q4 Earnings Snapshot	28/02	AQ
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results	28/02	AQ
MIMEDX to Present at TD Cowen 44th Annual Health Care Conference	20/02	AQ
MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28	12/02	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG	31/01	PR
MDXG INVESTOR NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages MiMedx Group, Inc. Investors to Inquire About Securities Class Action Investigation - MDXG	23/01	NE
Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG	23/01	PR
MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing	22/01	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués MiMedx Group Inc Nasdaq

Actions

US6024961012

Communiqués

Filtres